BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24510349)

  • 1. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.
    Li X; Guo X; Li H; Lin H; Sun Y
    Tumour Biol; 2014 Jun; 35(6):5281-6. PubMed ID: 24510349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis.
    Gui JC; Yan WL; Liu XD
    Clin Exp Med; 2014 May; 14(2):225-33. PubMed ID: 23456571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer.
    Zhang Y; Jiang L; Song L
    Minerva Med; 2016 Feb; 107(1):62-9. PubMed ID: 26824636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer.
    Wang X; Liu J; Xi H; Cai L
    Tumour Biol; 2014 Jul; 35(7):6893-900. PubMed ID: 24737583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis.
    Huang Z; Liu F
    Tumour Biol; 2014 Aug; 35(8):7459-65. PubMed ID: 24789274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.
    Wang S; Chen X; Tang M
    Tumour Biol; 2014 Aug; 35(8):7897-904. PubMed ID: 24828013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis.
    Zhang J; Xv Z; Wu X; Li K
    PLoS One; 2012; 7(12):e52896. PubMed ID: 23285221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of the diagnostic role of MUC1 in pancreatic ductal adenocarcinoma.
    Wang S; Chen X; Tang M
    Tumour Biol; 2014 Sep; 35(9):9101-9. PubMed ID: 25027396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
    Yang Y; Yan S; Tian H; Bao Y
    Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: a meta-analysis.
    Chen G; Liu S; Zhao Y; Dai M; Zhang T
    Pancreatology; 2013; 13(3):298-304. PubMed ID: 23719604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of serum macrophage inhibitory cytokine-1 in pancreatic cancer: a meta-analysis and meta-regression analysis.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Jun; 33(6):370-7. PubMed ID: 24592997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic accuracy of artery peak velocity variation measured by bedside real-time ultrasound for prediction of fluid responsiveness: a Meta-analysis].
    Pei Y; Yang Y; Feng Y; He S; Zhou J; Jiang H; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):99-105. PubMed ID: 32148240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis.
    Zhang A; Cai Y; Wang PF; Qu JN; Luo ZC; Chen XD; Huang B; Liu Y; Huang WQ; Wu J; Yin YH
    Crit Care; 2016 Feb; 20():41. PubMed ID: 26880194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.
    Dong D; Jia L; Zhang L; Ma N; Zhang A; Zhou Y; Ren L
    Cancer Sci; 2018 Sep; 109(9):2841-2851. PubMed ID: 29945294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy of REG Proteins as a Diagnostic Biomarker for Pancreatic Cancer: a Meta-Analysis.
    Liu C; Yang Y; Qian D; Tian Y; Li ML; Pu XY; You YQ; Zhang LQ
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis.
    Cao S; Hu Y; Gao X; Liao Q; Zhao Y
    PLoS One; 2016; 11(11):e0166406. PubMed ID: 27835676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.